☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
test
Share this
PS Admin
May 7, 2024
Magazine
test
dfdfgsdgsdg
Click here
to read the full press release
Comments
Fill this Details
×
Name
Email
Company Name
Thank you for download PDF
Submit
Related News/Articles
Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose of their COVID-19 Vaccine in Children Aged 5 Through 11 Years
April 27, 2022
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
January 12, 2022
GSK and Medicago Reports Results of COVID-19 Vaccine in P-III Study for the Treatment of COVID-19
December 8, 2021
Clover Initiates P-II Trial of COVID-19 Vaccine as Heterologous Booster for the Treatment of COVID-19
November 29, 2021
Moderna Reports Results of COVID-19 Vaccine in P-II/III KidCOVE Study for the Treatment of COVID-19
October 26, 2021
The US FDA Rejects Dynavax’ Four-Dose Heplisav-B Regimen for Adults on Hemodialysis
May 15, 2024
Dynavax Reports Preclinical Study Publication of TLR9 Agonist for Treatment of Lung Cancer
September 5, 2018
Moderna Reports the P-III Study Data of mRNA-1283 Vaccine to Prevent COVID-19
June 14, 2024
Moderna Receives Health Canada Authorization for Updated COVID-19 Vaccine SPIKEVAX XBB.1.5
September 13, 2023
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on COVIFENZ, a Plant-Based COVID-19 Vaccine
May 25, 2022
Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose of their COVID-19 Vaccine in Children Aged 5 Through 11 Years
April 27, 2022
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
January 12, 2022
GSK and Medicago Reports Results of COVID-19 Vaccine in P-III Study for the Treatment of COVID-19
December 8, 2021
Clover Initiates P-II Trial of COVID-19 Vaccine as Heterologous Booster for the Treatment of COVID-19
November 29, 2021
Moderna Reports Results of COVID-19 Vaccine in P-II/III KidCOVE Study for the Treatment of COVID-19
October 26, 2021
The US FDA Rejects Dynavax’ Four-Dose Heplisav-B Regimen for Adults on Hemodialysis
May 15, 2024
Dynavax Reports Preclinical Study Publication of TLR9 Agonist for Treatment of Lung Cancer
September 5, 2018
Moderna Reports the P-III Study Data of mRNA-1283 Vaccine to Prevent COVID-19
June 14, 2024
Moderna Receives Health Canada Authorization for Updated COVID-19 Vaccine SPIKEVAX XBB.1.5
September 13, 2023
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on COVIFENZ, a Plant-Based COVID-19 Vaccine
May 25, 2022
Liked our insights or summarized news?
Subscribe to our Daily/Weekly newsletter
×
Email
First Name
Last Name
Company Name
Area/Designation
Daily Newsletter
Weekly Newsletter
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions
X
Liked our insights or summarized news?
Subscribe to our Daily/Weekly newsletter
Subscribe
Modal title
×
Modal body text goes here.
